CAJ | 학술논문

目的:分析桂枝茯苓丸联合米非司酮治疗子宫肌瘤的疗效.方法:将2012年2月—2015年3月收治于我院的子宫肌瘤患者70例为研究对象,采用电脑数字随机分组方式将其均分成观察组35例及对照组35例.其中对照组患者单纯采用米非司酮治疗;而观察组患者采用桂枝茯苓丸联合米非司酮治疗.对两组患者的治疗效果及不良反应进行比较分析.结果:在经过不同的治疗后,观察组患者治愈19例、显效10例、有效4例、无效2例,治疗总有效率为94.3%(33/35);对照组患者治愈8例、显效12例、有效9例、无效6例,治疗总有效率为82.9%(29/35),同时观察组患者的不良反应为5.7%(2/35),对照组患者的不良反应为14.3%(5/35),两组间比较差异显著(P<0.05),具备统计学意义.结论:针对于子宫肌瘤患者而言,采用米非司酮联合桂枝茯苓丸给药的方式优于单纯采用米非司酮治疗,同时患者的不良反应较少,临床中值得推广使用.
목적:분석계지복령환연합미비사동치료자궁기류적료효.방법:장2012년2월—2015년3월수치우아원적자궁기류환자70례위연구대상,채용전뇌수자수궤분조방식장기균분성관찰조35례급대조조35례.기중대조조환자단순채용미비사동치료;이관찰조환자채용계지복령환연합미비사동치료.대량조환자적치료효과급불량반응진행비교분석.결과:재경과불동적치료후,관찰조환자치유19례、현효10례、유효4례、무효2례,치료총유효솔위94.3%(33/35);대조조환자치유8례、현효12례、유효9례、무효6례,치료총유효솔위82.9%(29/35),동시관찰조환자적불량반응위5.7%(2/35),대조조환자적불량반응위14.3%(5/35),량조간비교차이현저(P<0.05),구비통계학의의.결론:침대우자궁기류환자이언,채용미비사동연합계지복령환급약적방식우우단순채용미비사동치료,동시환자적불량반응교소,림상중치득추엄사용.
Objective: To analyze the therapeutic effect study of Guizhi Fuling Bolus combined with mifepristone in treating hysteromyoma. Methods: 70 patients with hysteromyoma, admitted to our hospital from February 2012 to March 2015 were randomly divided into the observation group and the control group evenly. The control group received mifepristone while the observation group received Guizhi Fuling Bolus combined with mifepristone, the therapeutic effects and the adverse reactions were compared. Results: The total efficiency of the control group was 82.9%, while that of the observation group was 94.3%, adverse reaction rate of the control group was 14.3%, while that of the observation group was 5.7%, the difference was statistically significant (P<0.05). Conclusion: The clinical therapeutic effect of Guizhi Fuling Bolus combined with mifepristone was remarkable in treating hysteromyoma and it was worthy of application.